<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:4dc17fff-a4b5-4990-a199-6cec09c385d3,g:616d6790-1169-4c4b-bc95-2884efae7446-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://novonordisk.com/role/AccountingMetricsDetails" xlink:type="simple" xlink:href="nvo-20201207.xsd#AccountingMetricsDetails"/>
  <link:presentationLink xlink:role="http://novonordisk.com/role/AccountingMetricsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAbstract_58f290b0-9090-4843-9fe6-32388fae2e52" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_BiotechnologyAndPharmaceuticalsIndustryAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAccountingMetricsAbstract_47eda5c2-d2f5-466d-aadd-5a88368939dd" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_BiotechnologyAndPharmaceuticalsIndustryAccountingMetricsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAbstract_58f290b0-9090-4843-9fe6-32388fae2e52" xlink:to="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAccountingMetricsAbstract_47eda5c2-d2f5-466d-aadd-5a88368939dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_SafetyOfClinicalTrialParticipantsDisclosureAbstract_ca45adca-05a8-4291-963b-0c6c46754167" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_SafetyOfClinicalTrialParticipantsDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAccountingMetricsAbstract_47eda5c2-d2f5-466d-aadd-5a88368939dd" xlink:to="loc_sasb_SafetyOfClinicalTrialParticipantsDisclosureAbstract_ca45adca-05a8-4291-963b-0c6c46754167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_ManagementProcessForEnsuringQualityAndPatientSafetyDuringClinicalTrialsTextBlock_acae7c18-00f7-4d37-848d-bb7e5e0912cf" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_ManagementProcessForEnsuringQualityAndPatientSafetyDuringClinicalTrialsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_SafetyOfClinicalTrialParticipantsDisclosureAbstract_ca45adca-05a8-4291-963b-0c6c46754167" xlink:to="loc_sasb_ManagementProcessForEnsuringQualityAndPatientSafetyDuringClinicalTrialsTextBlock_acae7c18-00f7-4d37-848d-bb7e5e0912cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_FdaInspectionsRelatedToClinicalTrialManagementAndPharmacovigilance_75765ebf-cdc8-4e14-8069-b474fbcebc06" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_FdaInspectionsRelatedToClinicalTrialManagementAndPharmacovigilance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_SafetyOfClinicalTrialParticipantsDisclosureAbstract_ca45adca-05a8-4291-963b-0c6c46754167" xlink:to="loc_sasb_FdaInspectionsRelatedToClinicalTrialManagementAndPharmacovigilance_75765ebf-cdc8-4e14-8069-b474fbcebc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_LossesAsAResultOfLegalProceedingsTable_077fffb2-7ada-430e-8ebd-22b12956753a" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_LossesAsAResultOfLegalProceedingsTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_SafetyOfClinicalTrialParticipantsDisclosureAbstract_ca45adca-05a8-4291-963b-0c6c46754167" xlink:to="loc_sasb_LossesAsAResultOfLegalProceedingsTable_077fffb2-7ada-430e-8ebd-22b12956753a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_LegalProceedingAssociationAxis_b8ad8038-2860-4c7e-95ee-c2ab7b5723f7" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_LegalProceedingAssociationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_LossesAsAResultOfLegalProceedingsTable_077fffb2-7ada-430e-8ebd-22b12956753a" xlink:to="loc_sasb_LegalProceedingAssociationAxis_b8ad8038-2860-4c7e-95ee-c2ab7b5723f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_LegalProceedingAssociationDomain_a2890d23-8e8a-43bb-87fc-764d6656af98" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_LegalProceedingAssociationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_LegalProceedingAssociationAxis_b8ad8038-2860-4c7e-95ee-c2ab7b5723f7" xlink:to="loc_sasb_LegalProceedingAssociationDomain_a2890d23-8e8a-43bb-87fc-764d6656af98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_ClinicalTrialsInDevelopingCountriesMember_d7421fea-e82d-41d0-acfa-3c539b3e3173" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_ClinicalTrialsInDevelopingCountriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_LegalProceedingAssociationDomain_a2890d23-8e8a-43bb-87fc-764d6656af98" xlink:to="loc_sasb_ClinicalTrialsInDevelopingCountriesMember_d7421fea-e82d-41d0-acfa-3c539b3e3173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_LossesAsAResultOfLegalProceedingsLineItems_48df0fa0-aeb9-4b66-ab80-454bfbd9a0c3" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_LossesAsAResultOfLegalProceedingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_LossesAsAResultOfLegalProceedingsTable_077fffb2-7ada-430e-8ebd-22b12956753a" xlink:to="loc_sasb_LossesAsAResultOfLegalProceedingsLineItems_48df0fa0-aeb9-4b66-ab80-454bfbd9a0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_LossesAsAResultOfLegalProceedings_0c25a744-70c3-4372-9d99-5a753fd6c042" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_LossesAsAResultOfLegalProceedings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_LossesAsAResultOfLegalProceedingsLineItems_48df0fa0-aeb9-4b66-ab80-454bfbd9a0c3" xlink:to="loc_sasb_LossesAsAResultOfLegalProceedings_0c25a744-70c3-4372-9d99-5a753fd6c042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_AffordabilityAndPricingDisclosureAbstract_13777e2d-f9f6-44c5-99da-f91fbf5f8172" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_AffordabilityAndPricingDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAccountingMetricsAbstract_47eda5c2-d2f5-466d-aadd-5a88368939dd" xlink:to="loc_sasb_AffordabilityAndPricingDisclosureAbstract_13777e2d-f9f6-44c5-99da-f91fbf5f8172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_ActionsAndInitiativesToPromoteAccessToHealthCareProductsForPriorityDiseasesAndInPriorityCountriesAsDefinedByTheAccessToMedicineIndexTextBlock_1c335be2-5bd5-4cd0-bd01-ca9ac8621d7e" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_ActionsAndInitiativesToPromoteAccessToHealthCareProductsForPriorityDiseasesAndInPriorityCountriesAsDefinedByTheAccessToMedicineIndexTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_AffordabilityAndPricingDisclosureAbstract_13777e2d-f9f6-44c5-99da-f91fbf5f8172" xlink:to="loc_sasb_ActionsAndInitiativesToPromoteAccessToHealthCareProductsForPriorityDiseasesAndInPriorityCountriesAsDefinedByTheAccessToMedicineIndexTextBlock_1c335be2-5bd5-4cd0-bd01-ca9ac8621d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_FdaEnforcementActionsTakenInResponseToViolationsOfCurrentGoodManufacturingPracticesTable_3fbf5a74-8430-41e4-b54f-bb6b67e41148" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_FdaEnforcementActionsTakenInResponseToViolationsOfCurrentGoodManufacturingPracticesTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAccountingMetricsAbstract_47eda5c2-d2f5-466d-aadd-5a88368939dd" xlink:to="loc_sasb_FdaEnforcementActionsTakenInResponseToViolationsOfCurrentGoodManufacturingPracticesTable_3fbf5a74-8430-41e4-b54f-bb6b67e41148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_FdaEnforcementActionAxis_c76a45fd-ef36-4fc5-acfe-3fb87a892da5" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_FdaEnforcementActionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_FdaEnforcementActionsTakenInResponseToViolationsOfCurrentGoodManufacturingPracticesTable_3fbf5a74-8430-41e4-b54f-bb6b67e41148" xlink:to="loc_sasb_FdaEnforcementActionAxis_c76a45fd-ef36-4fc5-acfe-3fb87a892da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_FdaEnforcementActionDomain_fd1ee1df-0408-4399-a90f-ecb70579088d" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_FdaEnforcementActionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_FdaEnforcementActionAxis_c76a45fd-ef36-4fc5-acfe-3fb87a892da5" xlink:to="loc_sasb_FdaEnforcementActionDomain_fd1ee1df-0408-4399-a90f-ecb70579088d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_FdaEnforcementActionsTakenInResponseToViolationsOfCurrentGoodManufacturingPracticesLineItems_a89d9a26-f75a-4768-9618-f161d8c68b79" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_FdaEnforcementActionsTakenInResponseToViolationsOfCurrentGoodManufacturingPracticesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_FdaEnforcementActionsTakenInResponseToViolationsOfCurrentGoodManufacturingPracticesTable_3fbf5a74-8430-41e4-b54f-bb6b67e41148" xlink:to="loc_sasb_FdaEnforcementActionsTakenInResponseToViolationsOfCurrentGoodManufacturingPracticesLineItems_a89d9a26-f75a-4768-9618-f161d8c68b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_DrugSafetyDisclosureAbstract_8365493c-3de9-451b-82e6-2ad86e62c2ae" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_DrugSafetyDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_FdaEnforcementActionsTakenInResponseToViolationsOfCurrentGoodManufacturingPracticesLineItems_a89d9a26-f75a-4768-9618-f161d8c68b79" xlink:to="loc_sasb_DrugSafetyDisclosureAbstract_8365493c-3de9-451b-82e6-2ad86e62c2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_ProductRecalls_375742bd-4ea7-4b49-840b-27cb2657b881" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_ProductRecalls"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_DrugSafetyDisclosureAbstract_8365493c-3de9-451b-82e6-2ad86e62c2ae" xlink:to="loc_sasb_ProductRecalls_375742bd-4ea7-4b49-840b-27cb2657b881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_FdaEnforcementActionsTakenInResponseToViolationsOfCurrentGoodManufacturingPractices_62b7bb1f-f6aa-4353-b546-51eca103fee1" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_FdaEnforcementActionsTakenInResponseToViolationsOfCurrentGoodManufacturingPractices"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_DrugSafetyDisclosureAbstract_8365493c-3de9-451b-82e6-2ad86e62c2ae" xlink:to="loc_sasb_FdaEnforcementActionsTakenInResponseToViolationsOfCurrentGoodManufacturingPractices_62b7bb1f-f6aa-4353-b546-51eca103fee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_CounterfeitDrugsDisclosureAbstract_a90ba5e7-daa7-4845-bc7f-74ad99ec4ae4" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_CounterfeitDrugsDisclosureAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAccountingMetricsAbstract_47eda5c2-d2f5-466d-aadd-5a88368939dd" xlink:to="loc_sasb_CounterfeitDrugsDisclosureAbstract_a90ba5e7-daa7-4845-bc7f-74ad99ec4ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_MethodsAndTechnologiesUsedToMaintainTraceabilityOfProductsThroughoutTheDistributionChainTextBlock_d063db62-4e2e-40e7-a521-2c4673642ebf" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_MethodsAndTechnologiesUsedToMaintainTraceabilityOfProductsThroughoutTheDistributionChainTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_CounterfeitDrugsDisclosureAbstract_a90ba5e7-daa7-4845-bc7f-74ad99ec4ae4" xlink:to="loc_sasb_MethodsAndTechnologiesUsedToMaintainTraceabilityOfProductsThroughoutTheDistributionChainTextBlock_d063db62-4e2e-40e7-a521-2c4673642ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_CounterfeitProductsProcessForAlertingCustomersAndBusinessPartnersOfPotentialOrKnownRisksTextBlock_10a09de7-7f47-4a35-a899-24976c83f8a4" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_CounterfeitProductsProcessForAlertingCustomersAndBusinessPartnersOfPotentialOrKnownRisksTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_CounterfeitDrugsDisclosureAbstract_a90ba5e7-daa7-4845-bc7f-74ad99ec4ae4" xlink:to="loc_sasb_CounterfeitProductsProcessForAlertingCustomersAndBusinessPartnersOfPotentialOrKnownRisksTextBlock_10a09de7-7f47-4a35-a899-24976c83f8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EthicalMarketingDisclosureAbstract_3df14c0f-a6f3-4555-a797-6c69cc5b53d2" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EthicalMarketingDisclosureAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAccountingMetricsAbstract_47eda5c2-d2f5-466d-aadd-5a88368939dd" xlink:to="loc_sasb_EthicalMarketingDisclosureAbstract_3df14c0f-a6f3-4555-a797-6c69cc5b53d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeeRecruitmentDevelopmentAndRetentionDisclosureAbstract_78b1c262-326a-4925-9b93-d4af245e53a9" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeeRecruitmentDevelopmentAndRetentionDisclosureAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAccountingMetricsAbstract_47eda5c2-d2f5-466d-aadd-5a88368939dd" xlink:to="loc_sasb_EmployeeRecruitmentDevelopmentAndRetentionDisclosureAbstract_78b1c262-326a-4925-9b93-d4af245e53a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeeTurnoverRateInvoluntaryTable_29dc67fd-ef0f-4960-8954-0300df0ee460" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeeTurnoverRateInvoluntaryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeeRecruitmentDevelopmentAndRetentionDisclosureAbstract_78b1c262-326a-4925-9b93-d4af245e53a9" xlink:to="loc_sasb_EmployeeTurnoverRateInvoluntaryTable_29dc67fd-ef0f-4960-8954-0300df0ee460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeeTypeAxis_79d70684-ea9d-49a4-af2b-e1039e9c0527" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeeTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeeTurnoverRateInvoluntaryTable_29dc67fd-ef0f-4960-8954-0300df0ee460" xlink:to="loc_sasb_EmployeeTypeAxis_79d70684-ea9d-49a4-af2b-e1039e9c0527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeeTypeDomain_33d73012-f67e-496c-9bf1-c3d91af6fc0e" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeeTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeeTypeAxis_79d70684-ea9d-49a4-af2b-e1039e9c0527" xlink:to="loc_sasb_EmployeeTypeDomain_33d73012-f67e-496c-9bf1-c3d91af6fc0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeeTurnoverRateInvoluntaryLineItems_d981dd56-7af9-423c-8f14-ac9d0f869455" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeeTurnoverRateInvoluntaryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeeTurnoverRateInvoluntaryTable_29dc67fd-ef0f-4960-8954-0300df0ee460" xlink:to="loc_sasb_EmployeeTurnoverRateInvoluntaryLineItems_d981dd56-7af9-423c-8f14-ac9d0f869455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeeTurnoverRateInvoluntary_c897f787-31a4-4da0-9df2-98d1a41520d5" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeeTurnoverRateInvoluntary"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeeTurnoverRateInvoluntaryLineItems_d981dd56-7af9-423c-8f14-ac9d0f869455" xlink:to="loc_sasb_EmployeeTurnoverRateInvoluntary_c897f787-31a4-4da0-9df2-98d1a41520d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeeTurnoverRateVoluntaryTable_2ff3c886-c4cb-4e47-8abe-100de1b4f8df" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeeTurnoverRateVoluntaryTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeeRecruitmentDevelopmentAndRetentionDisclosureAbstract_78b1c262-326a-4925-9b93-d4af245e53a9" xlink:to="loc_sasb_EmployeeTurnoverRateVoluntaryTable_2ff3c886-c4cb-4e47-8abe-100de1b4f8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeeTypeAxis_aa6abfba-a62d-4f10-a2a6-c7a6e42c12c1" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeeTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeeTurnoverRateVoluntaryTable_2ff3c886-c4cb-4e47-8abe-100de1b4f8df" xlink:to="loc_sasb_EmployeeTypeAxis_aa6abfba-a62d-4f10-a2a6-c7a6e42c12c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeeTypeDomain_d3dd36c3-f98d-4abc-87e6-1369249c656e" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeeTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeeTurnoverRateVoluntaryLineItems_b6926b56-4f3c-4411-9c62-1a10df9c36c6" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeeTurnoverRateVoluntaryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeeTurnoverRateVoluntaryTable_2ff3c886-c4cb-4e47-8abe-100de1b4f8df" xlink:to="loc_sasb_EmployeeTurnoverRateVoluntaryLineItems_b6926b56-4f3c-4411-9c62-1a10df9c36c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeeTurnoverRateVoluntary_8342237b-7cee-497c-bba2-e13aaefffb1c" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeeTurnoverRateVoluntary"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeeTurnoverRateVoluntaryLineItems_b6926b56-4f3c-4411-9c62-1a10df9c36c6" xlink:to="loc_sasb_EmployeeTurnoverRateVoluntary_8342237b-7cee-497c-bba2-e13aaefffb1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_SupplyChainManagementDisclosureAbstract_07644b73-0cde-472f-8198-5fe5ae00153b" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_SupplyChainManagementDisclosureAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAccountingMetricsAbstract_47eda5c2-d2f5-466d-aadd-5a88368939dd" xlink:to="loc_sasb_SupplyChainManagementDisclosureAbstract_07644b73-0cde-472f-8198-5fe5ae00153b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgramTable_ffe0641b-b4c1-4db8-8264-cbba967f8ea5" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgramTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_SupplyChainManagementDisclosureAbstract_07644b73-0cde-472f-8198-5fe5ae00153b" xlink:to="loc_sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgramTable_ffe0641b-b4c1-4db8-8264-cbba967f8ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_SupplierTierAxis_ce53793b-c14b-442a-bb77-52b8f245310a" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_SupplierTierAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgramTable_ffe0641b-b4c1-4db8-8264-cbba967f8ea5" xlink:to="loc_sasb_SupplierTierAxis_ce53793b-c14b-442a-bb77-52b8f245310a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_SupplierTierDomain_6d27e94b-5a39-4623-a772-8750366f8a3d" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_SupplierTierDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_SupplierTierAxis_ce53793b-c14b-442a-bb77-52b8f245310a" xlink:to="loc_sasb_SupplierTierDomain_6d27e94b-5a39-4623-a772-8750366f8a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgramLineItems_09d4e113-5d4f-4434-bb62-cb848b692682" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgramLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgramTable_ffe0641b-b4c1-4db8-8264-cbba967f8ea5" xlink:to="loc_sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgramLineItems_09d4e113-5d4f-4434-bb62-cb848b692682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgram_7a7d03c4-d1e9-4d1b-a3a5-6ef7f5f2d9c2" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgram"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgramLineItems_09d4e113-5d4f-4434-bb62-cb848b692682" xlink:to="loc_sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgram_7a7d03c4-d1e9-4d1b-a3a5-6ef7f5f2d9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EntityFacilitiesPercentageParticipatingInThePharmaceuticalSupplyChainConsortiumAuditProgram_cadb50c5-6360-4495-932c-cf7554980a2c" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EntityFacilitiesPercentageParticipatingInThePharmaceuticalSupplyChainConsortiumAuditProgram"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_SupplierFacilitiesPercentageParticipatingInPharmaceuticalSupplyChainConsortiumAuditProgramLineItems_09d4e113-5d4f-4434-bb62-cb848b692682" xlink:to="loc_sasb_EntityFacilitiesPercentageParticipatingInThePharmaceuticalSupplyChainConsortiumAuditProgram_cadb50c5-6360-4495-932c-cf7554980a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_BusinessEthicsDisclosureAbstract_26d4a2ae-2c53-4329-a151-12ebae2e4461" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_BusinessEthicsDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAccountingMetricsAbstract_47eda5c2-d2f5-466d-aadd-5a88368939dd" xlink:to="loc_sasb_BusinessEthicsDisclosureAbstract_26d4a2ae-2c53-4329-a151-12ebae2e4461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_LossesAsAResultOfLegalProceedingsTable_e8602b6d-936a-42a1-b742-e4364b0fa613" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_LossesAsAResultOfLegalProceedingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BusinessEthicsDisclosureAbstract_26d4a2ae-2c53-4329-a151-12ebae2e4461" xlink:to="loc_sasb_LossesAsAResultOfLegalProceedingsTable_e8602b6d-936a-42a1-b742-e4364b0fa613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_LegalProceedingAssociationAxis_d5167a73-a011-4313-9dc9-1031061f32a6" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_LegalProceedingAssociationAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_LegalProceedingAssociationDomain_a11db58b-baea-4087-ad66-6bcaceddcf0e" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_LegalProceedingAssociationDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_CorruptionAndBriberyMember_6556ebe7-3174-4939-b0c9-a1e11dfa2194" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_CorruptionAndBriberyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_LegalProceedingAssociationDomain_a11db58b-baea-4087-ad66-6bcaceddcf0e" xlink:to="loc_sasb_CorruptionAndBriberyMember_6556ebe7-3174-4939-b0c9-a1e11dfa2194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_LossesAsAResultOfLegalProceedingsLineItems_130eed6d-12a9-4a8c-ada6-b3cb3eb3fadc" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_LossesAsAResultOfLegalProceedingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_LossesAsAResultOfLegalProceedings_e90b51e8-93d6-4158-aa17-1c5f25b5bd40" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_LossesAsAResultOfLegalProceedings"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_CodeOfEthicsGoverningInteractionsWithHealthCareProfessionalsTextBlock_859956dd-bda1-4354-9e4e-36d39cf88c6a" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_CodeOfEthicsGoverningInteractionsWithHealthCareProfessionalsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BusinessEthicsDisclosureAbstract_26d4a2ae-2c53-4329-a151-12ebae2e4461" xlink:to="loc_sasb_CodeOfEthicsGoverningInteractionsWithHealthCareProfessionalsTextBlock_859956dd-bda1-4354-9e4e-36d39cf88c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://novonordisk.com/role/ActivityMetricsDetails" xlink:type="simple" xlink:href="nvo-20201207.xsd#ActivityMetricsDetails"/>
  <link:presentationLink xlink:role="http://novonordisk.com/role/ActivityMetricsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAbstract_98b830c1-ca1d-4f6e-b287-67ceda71edaf" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_BiotechnologyAndPharmaceuticalsIndustryAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryActivityMetricsAbstract_d10c130a-fcfd-4665-b2a2-288a4c358acc" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_BiotechnologyAndPharmaceuticalsIndustryActivityMetricsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryAbstract_98b830c1-ca1d-4f6e-b287-67ceda71edaf" xlink:to="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryActivityMetricsAbstract_d10c130a-fcfd-4665-b2a2-288a4c358acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_PatientsTreatedNumber_8131e87b-1599-49a7-8648-d650899b2596" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_PatientsTreatedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryActivityMetricsAbstract_d10c130a-fcfd-4665-b2a2-288a4c358acc" xlink:to="loc_sasb_PatientsTreatedNumber_8131e87b-1599-49a7-8648-d650899b2596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_DrugsInPortfolioNumber_9509aa3b-e828-4dbf-8c46-e9896cc1f26b" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_DrugsInPortfolioNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryActivityMetricsAbstract_d10c130a-fcfd-4665-b2a2-288a4c358acc" xlink:to="loc_sasb_DrugsInPortfolioNumber_9509aa3b-e828-4dbf-8c46-e9896cc1f26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_DrugsInResearchAndDevelopmentNumber_430ff3b1-c613-442f-b0b2-143f816f06fc" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_DrugsInResearchAndDevelopmentNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_BiotechnologyAndPharmaceuticalsIndustryActivityMetricsAbstract_d10c130a-fcfd-4665-b2a2-288a4c358acc" xlink:to="loc_sasb_DrugsInResearchAndDevelopmentNumber_430ff3b1-c613-442f-b0b2-143f816f06fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://novonordisk.com/role/ConsumerGoodsECommerceCGECStatement" xlink:type="simple" xlink:href="nvo-20201207.xsd#ConsumerGoodsECommerceCGECStatement"/>
  <link:presentationLink xlink:role="http://novonordisk.com/role/ConsumerGoodsECommerceCGECStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeesPercentageOfManagementTable_a5f810a5-abd8-4268-b9b5-19c79d143077" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeesPercentageOfManagementTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_GenderAxis_29355f1c-c16a-4977-a21f-b0bd06484284" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_GenderAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeesPercentageOfManagementTable_a5f810a5-abd8-4268-b9b5-19c79d143077" xlink:to="loc_sasb_GenderAxis_29355f1c-c16a-4977-a21f-b0bd06484284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_GenderDomain_00fde153-0cf6-4d8f-8af6-f4fc19a65a5d" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_GenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_GenderAxis_29355f1c-c16a-4977-a21f-b0bd06484284" xlink:to="loc_sasb_GenderDomain_00fde153-0cf6-4d8f-8af6-f4fc19a65a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_MaleMember_19f1f6a1-33ab-4117-b218-8cb89df42e52" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_MaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_GenderDomain_00fde153-0cf6-4d8f-8af6-f4fc19a65a5d" xlink:to="loc_sasb_MaleMember_19f1f6a1-33ab-4117-b218-8cb89df42e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_FemaleMember_93844edf-c992-4e24-9128-9d04e78b078e" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_FemaleMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_GenderDomain_00fde153-0cf6-4d8f-8af6-f4fc19a65a5d" xlink:to="loc_sasb_FemaleMember_93844edf-c992-4e24-9128-9d04e78b078e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeesPercentageOfManagementLineItems_5b0b5fa7-6bbb-43e1-b052-aca746b6ae81" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeesPercentageOfManagementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeesPercentageOfManagementTable_a5f810a5-abd8-4268-b9b5-19c79d143077" xlink:to="loc_sasb_EmployeesPercentageOfManagementLineItems_5b0b5fa7-6bbb-43e1-b052-aca746b6ae81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeesNumber_8ae7a37c-21e4-4dc3-a9cb-99397c8d1f7a" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeesNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeesPercentageOfManagementLineItems_5b0b5fa7-6bbb-43e1-b052-aca746b6ae81" xlink:to="loc_sasb_EmployeesNumber_8ae7a37c-21e4-4dc3-a9cb-99397c8d1f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeeEngagementPercentage_e4aa8206-9f1e-4dba-b28f-143b92714c7b" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeeEngagementPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeesPercentageOfManagementLineItems_5b0b5fa7-6bbb-43e1-b052-aca746b6ae81" xlink:to="loc_sasb_EmployeeEngagementPercentage_e4aa8206-9f1e-4dba-b28f-143b92714c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sasb_EmployeesPercentageOfManagement_460fe036-72e0-469a-8217-36a5e1e0fb9a" xlink:href="http://www.sasb.org/xbrl/taxonomy/cor/sasb.xsd#sasb_EmployeesPercentageOfManagement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sasb_EmployeesPercentageOfManagementLineItems_5b0b5fa7-6bbb-43e1-b052-aca746b6ae81" xlink:to="loc_sasb_EmployeesPercentageOfManagement_460fe036-72e0-469a-8217-36a5e1e0fb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
